pharmaphorum

NOVEMBER 28, 2019

Pharmaceutical companies spend a huge amount of time and resources on creating valuable brand strategies, but when they come to life there’s often a disconnect. Strategy and execution can easily drift apart when tactics come to life, making it harder for them to drive business and deliver on the long-term action plans to engage with healthcare professionals.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Fuld

NOVEMBER 26, 2019

Michael Ratcliffe brings both deep industry expertise and intelligence and strategy consulting capabilities to the firm. Boston, Mass. November 26, 2019 — Fuld + Company, a global competitive strategy consultancy, today announced the recent appointment of Michael Ratcliffe as a Senior Director and Head of the Health & Life Sciences Practice.

Insurance 52

Insurance 52

Fossil Remedies

NOVEMBER 21, 2019

What is the difference between the pharma sector and other sectors? Experts rate the pharma sector quite higher than others because of its huge potential for growth. Because of the tremendous progress in the Indian economy, every pharma company can expect good earnings. However, it is also essential to know about the ways of expanding and popularizing the business.

Documentation 52

Documentation 52

The Nontraditional Pharmacist

NOVEMBER 20, 2019

Will Soliman, Chairman and CEO, of Accreditation Council for Medical Affairs (ACMA) discusses the exciting opportunities available to pharmacists in the pharma industry and how to pursue them. Name: William Soliman. Title: Chairman, Accreditation Council for Medical Affairs (ACMA). Program: Board Certified Medical Affairs Specialist (BCMAS). Interview Summary.

Communication 52

Communication 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

SingleCare

NOVEMBER 18, 2019

As a pharmacist, helping people is part of your job. For many, it’s why you decided to join the healthcare field, and what drives you—making sure your patients are happy and healthy. You’re already working to make the world a better place and giving back to the community on a daily basis. But, during the holiday season, it’s even more important to help those in need. 9 ideas for giving back to the community The season of gifts and good cheer is hard for people who are struggling—financially, em

Health and Personal Care Stores 52

Health and Personal Care Stores Nursing Homes Packaging Hospitals 52

Med Ed 101

NOVEMBER 27, 2019

I have seen the prescribing cascade happen in clinical practice far too many times! One of those classic examples is heart failure. A patient is placed on a new medication that contributes to edema and heart failure. With a period of days to weeks, that patient is then placed on diuretics or doses have had […]. The post Top 5 Medications to Avoid In Heart Failure appeared first on Med Ed 101.

40

40

Med Ed 101

NOVEMBER 20, 2019

I’m working on a new book that I’m super excited about! I’m writing a book on drug interactions and hope to finish by the end of the year! I’m tackling the top 200 drugs plus those I consider very clinically relevant in practice. My hope is that it is a perfect resource for ambulatory care, […]. The post Carbamazepine Interactions – What to do About Them?

40

40

Med Ed 101

NOVEMBER 17, 2019

Insomnia is a sneaky condition that can lead to polypharmacy. Many of the medications used in the management of insomnia can work for a short period of time, but I’ve seen so many cases where the effects wear off over time. Always remember to do our due diligence on non-pharmacologic interventions! Here’s a case scenario […]. The post Insomnia Polypharmacy appeared first on Med Ed 101.

40

40

Med Ed 101

NOVEMBER 13, 2019

I’m saddened for some of my friends and colleagues who’ve recently lost their job. The recent move by HealthPartners in my own state hits close to home. HealthPartners is closing up 30 retail pharmacies and this means further tightening of the saturated job market. If you are looking at the traditional pharmacy workforce, the 2020 […].

40

40

Med Ed 101

NOVEMBER 10, 2019

Metformin is the go-to first-line medication in type 2 diabetes. While drug interactions aren’t incredibly common with its use, we should be aware of OCT inhibition and the potential effects that this might cause. Under normal circumstances, this isn’t necessarily a drug interaction that will be life-threatening, but one that could have some mild to […].

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Med Ed 101

NOVEMBER 6, 2019

In the case scenario below, I discuss the implications of the verapamil phenytoin interaction. JS is a 38-year-old male who has been on phenytoin for seizure prophylaxis for several years. He reports to his primary care provider complaining of severe headaches. He is diagnosed with cluster headaches. Over the next year, he continues to have […].

40

40

Med Ed 101

NOVEMBER 3, 2019

KS is a 79-year-old female. She states that she takes too many pills and would like to try to reduce some. Here’s her list. Aspirin 81 mg daily Clopidogrel 75 mg daily Pantoprazole 40 mg daily Valsartan 80 mg daily Metoprolol 25 mg BID Amlodipine 5 mg daily Mirtazapine 15 mg at bedtime Famotidine 20 […]. The post Case Scenario: Polypharmacy List Review appeared first on Med Ed 101.

40

40